Mel Sorensen
-
Malvern-based Galera Therapeutics to Be Acquired In Reverse Merger
Malvern-based Galera Therapeutics will be acquired by Obsidian Therapeutics in an all-stock reverse merger, writes John George for the Philadelphia Business Journal. The two companies have secured a $350 million private…
-
Malvern-Based Galera Therapeutics Sells Drug Portfolio for Up to $105 Million
Following an FDA setback, Malvern-based Galera Therapeutics is selling its drug portfolio to the Canadian biotechnology firm Biossil in a deal that has been valued…
-
Malvern-based Galera Therapeutics Secures New Lease on Life with Acquirement Underway
Four months after its board of directors began dissolving the company, Galera Therapeutics secured a lifeline by acquiring Nova Pharmaceuticals, a privately held biotechnology firm,…
-
One Year After FDA Rejects Its Lead Candidate, Malvern-based Galera Therapeutics Moves to Dissolve
Malvern-based Galera Therapeutics is moving forward with a plan to shut down the company and liquidate all of its assets, writes John George for the…
-
Malvern-Based Galera Therapeutics Exploring Ways to Remain Afloat
Malvern-based Galera Therapeutics is continuing to explore alternatives that would allow it to persevere, writes John George for the Philadelphia Business Journal. Earlier this week,…
-
Malvern-based Galera Therapeutics Looks for Ways to Stay Afloat with Help from Third Party
After failing to convince the Food and Drug Administration that there is no need for additional testing for its lead new drug candidate, Malvern-based Galera…
-
Malvern’s Galera Therapeutics Developing Solutions to Improve Treatment, Outcomes for Cancer Patients
Malvern-based Galera Therapeutics is developing solutions that are reducing the negative side effects of radiation therapy and helping to improve treatment and outcomes for cancer…
-
Buoyed by Drug to Fight Radiation Sickness in Cancer Patients, Malvern’s Galera Therapeutics Goes Public
At $12 a share, Malvern-based Galera Therapeutics raised $60 million in its initial public offering and is now trading under the GRTX symbol on the…



















































